Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.2.1)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-15

Query Trace: Coronary Disease and PTGS1[orginal query]

A study into the genetic basis of aspirin resistance in Pakistani patients with coronary artery disease. Pakistan journal of pharmaceutical sciences 2016 Jul 29 (4): 1177-82. Mukarram Osama, Akhtar Naveed, Junaid Ayesha, Mohyuddin Ais Similar articles in PubMed
Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. Lupus 2014 Aug 23 (9): 876-80. Chung C P, Solus J F, Oeser A, Li C, Raggi P, Smith J R, Stein C Similar articles in PubMed
Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1. PloS one 2014 9 (10): e111816. Würtz Morten, Nissen Peter H, Grove Erik Lerkevang, Kristensen Steen Dalby, Hvas Anne-Met Similar articles in PubMed
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology 2013 Sep 167 (6): 2882-8. Verschuren Jeffrey J W, Boden Helèn, Wessels Judith A M, van der Hoeven Bas L, Trompet Stella, Heijmans Bastiaan T, Putter Hein, Guchelaar Henk-Jan, Schalij Martin J, Jukema J Wout Similar articles in PubMed
Genetic determinants of response to aspirin: appraisal of 4 candidate genes. Thrombosis research 2011 Jul 128 (1): 47-53. Lordkipanidzé Marie, Diodati Jean G, Palisaitis Donald A, Schampaert Erick, Turgeon Jacques, Pharand Chant Similar articles in PubMed
Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. American heart journal 2011 Jul 162 (1): 166-72.e1. Voora Deepak, Horton John, Shah Svati H, Shaw Linda K, Newby L Krist Similar articles in PubMed
A common promoter variant of the gene encoding cyclooxygenase-1 (PTGS1) is related to decreased incidence of myocardial infarction in patients with coronary artery disease. Thrombosis research 2011 Jun 127 (6): 600-2. Licis Normunds, Krivmane Baiba, Latkovskis Gustavs, Erglis Andre Similar articles in PubMed
Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 2009 Dec 120 (24): 2448-54. McGeachie Michael, Ramoni Rachel L Badovinac, Mychaleckyj Josyf C, Furie Karen L, Dreyfuss Jonathan M, Liu Yongmei, Herrington David, Guo Xiuqing, Lima João A, Post Wendy, Rotter Jerome I, Rich Stephen, Sale Michèle, Ramoni Marco Similar articles in PubMed
High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009 Jun 20 (4): 257-62. Motovska Zuzana, Widimsky Petr, Kvasnicka Jan, Petr Robert, Bilkova Dana, Hajkova Jaroslava, Marinov Iuri, Simek Stanislav, Kala Petr, Similar articles in PubMed
Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease. Thrombosis and haemostasis 2009 Jan 101 (1): 123-33. Kunicki Thomas J, Williams Shirley A, Nugent Diane J, Harrison Paul, Segal Helen C, Syed Anila, Rothwell Peter Similar articles in PubMed
Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease. Thrombosis and haemostasis 2008 Nov 100 (5): 893-8. Szczeklik Wojciech, Sanak Marek, Rostoff Pawel, Piwowarska Wieslawa, Jakiela Bogdan, Szczeklik Andr Similar articles in PubMed
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Clinical pharmacology and therapeutics 2008 Jan 83 (1): 52-60. Lee C R, North K E, Bray M S, Couper D J, Heiss G, Zeldin D Similar articles in PubMed
Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism. Platelets 2006 May 17 (3): 163-9. Kranzhofer Roger, Ruef Johann Similar articles in PubMed
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. Thrombosis and haemostasis 2006 Feb 95 (2): 253-9. Lepäntalo Aino, Mikkelsson Jussi, Reséndiz Julio C, Viiri Leena, Backman Janne T, Kankuri Esko, Karhunen Pekka J, Lassila Riit Similar articles in PubMed
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients. Genetic testing and molecular biomarkers 0 15 (7-8): 513-6. Chakroun Tahar, Addad Faouzi, Yacoub Saloua, Abderrezak Fatma, Gerotziafas Gregoris T, Abdelkafi Sadia, Hassine Mohssen, Gamra Habib, Hatmi Mohamed, Elalamy Isma Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Mar 16, 2019
Page last updated:Apr 09, 2020
Content source:

TOP